Lonely in Depression
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFriedrich-Alexander-Universität Erlangen-Nürnberg
About this trial
The goal of this prospective study is to better understand the link between loneliness and depression in the inpatient psychiatric treatment of depression. It aims to answer:
Do lonely and not lonely persons benefit the same way from inpatient depression treatment? Is loneliness a clinical relevant factor in inpatient treatment of depression? What are the underlying biopsychosocial mechanisms?
Participants will be asked to do some
* self-report questionnaires * clinical interview * biosampling (blood, saliva, stool) at three main measurement timepoints (1. begin of inpatient treatment, 2. day of discharge, 3. three months after discharge).
Eligibility criteria
Qualifiers
primary diagnosis of depression according to ICD-10 (F32 or F33), as diagnosed by a physician or clinical psychologist in conjunction with the M.I.N.I. Mini-International Neuropsychiatric Interview diagnostic tools
inpatient elective or emergency admission to one of the two psychiatric clinics; - age over 18 years
sufficient understanding of spoken and written German
informed voluntary consent
Disqualifiers
a current lack of capacity to provide consent (e.g., pronounced psychotic symptoms, stuporous depressive syndrome, and thought constriction to suicidality)
previous participation in the study
pregnancy or breastfeeding
inpatient stay of less than 7 days, even if the patients initially met the inclusion criteria.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Friedrich-Alexander-Universität Erlangen-Nürnberg
Lead sponsor
Bezirkskliniken Mittelfranken, Clinic for Psychiatry, Addiction, Psychotherapie and Psychosomatic Medicine, Am Europakanal, Germany
Collaborator
Source ClinicalTrials.gov